JACC
HOME SUBSCRIPTIONS CURRENT ISSUE PAST ISSUES CARDIOSOURCE SEARCH HELP FEEDBACK
 QUICK SEARCH:   [advanced]


     


J Am Coll Cardiol, 1995; 25:1225-1231
© 1995 by the American College of Cardiology Foundation
This Article
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Olsen, S.
Right arrow Articles by Bristow, M.
Right arrow Search for Related Content
PubMed
Right arrow Articles by Olsen, S.
Right arrow Articles by Bristow, M.

Carvedilol improves left ventricular function and symptoms in chronic heart failure: a double-blind randomized study

SL Olsen, EM Gilbert, DG Renlund, DO Taylor, FD Yanowitz, and MR Bristow

Division of Cardiology, University of Utah Health Sciences Center, Salt Lake City 84132, USA.

OBJECTIVES. This study assessed the safety and efficacy of carvedilol in patients with heart failure caused by idiopathic or ischemic cardiomyopathy. BACKGROUND. Carvedilol is a mildly beta 1-selective beta-adrenergic blocking agent with vasodilator properties. Beta-blockade may be beneficial in patients with heart failure, but the effects of carvedilol are not known. METHODS. Sixty patients with heart failure (New York Heart Association functional classes II to IV) and left ventricular ejection fraction < or = 0.35 were enrolled in the study. All patients tolerated challenge with carvedilol, 3.125 mg twice a day, and were randomized to receive carvedilol (n = 36) versus placebo (n = 24). Study medication was titrated over 1 month from 6.25 to 25 mg twice a day (< 75 kg) or 50 mg twice a day (> 75 kg) and continued for 3 months. One placebo-treated and two carvedilol-treated patients did not complete the study. RESULTS. Carvedilol therapy resulted in a significant reduction in heart rate and mean pulmonary artery and pulmonary capillary wedge pressures and a significant increase in stroke volume and left ventricular stroke work. Left ventricular ejection fraction increased 52% in the carvedilol group (from 0.21 to 0.32, p < 0.0001 vs. placebo group). Carvedilol-treated patients also reported a significant lessening of heart failure symptoms (p < 0.05 vs. placebo group). Submaximal exercise duration tended to increase with carvedilol therapy (from 688 +/- 31 s to 871 +/- 32 s), but this change was not significantly different from that with placebo therapy by between-group analysis. Peak oxygen consumption during maximal exercise did not change. CONCLUSIONS. Long-term carvedilol therapy improves rest cardiac function and lessens symptoms in patients with heart failure.


This article has been cited by other articles:


Home page
Eur Heart JHome page
I. A. Nasr, A. Bouzamondo, J.-S. Hulot, O. Dubourg, J.-Y. Le Heuzey, and P. Lechat
Prevention of atrial fibrillation onset by beta-blocker treatment in heart failure: a meta-analysis
Eur. Heart J., February 8, 2007; (2007) ehl484v1.
[Abstract] [Full Text] [PDF]


Home page
Eur Heart J SupplHome page
C. Funck-Brentano
Beta-blockade in CHF: from contraindication to indication
Eur. Heart J. Suppl., June 1, 2006; 8(suppl_C): C19 - C27.
[Abstract] [Full Text] [PDF]


Home page
JNMHome page
A. Cohen-Solal, F. Rouzet, A. Berdeaux, D. Le Guludec, E. Abergel, A. Syrota, and P. Merlet
Effects of Carvedilol on Myocardial Sympathetic Innervation in Patients with Chronic Heart Failure
J. Nucl. Med., November 1, 2005; 46(11): 1796 - 1803.
[Abstract] [Full Text] [PDF]


Home page
J Am Coll CardiolHome page
Developed in Collaboration With the American Colle, Endorsed by the Heart Rhythm Society, S. A. Hunt, W. T. Abraham, M. H. Chin, A. M. Feldman, G. S. Francis, T. G. Ganiats, M. Jessup, M. A. Konstam, et al.
ACC/AHA 2005 Guideline Update for the Diagnosis and Management of Chronic Heart Failure in the Adult--Summary Article: A Report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Writing Committee to Update the 2001 Guidelines for the Evaluation and Management of Heart Failure)
J. Am. Coll. Cardiol., September 20, 2005; 46(6): 1116 - 1143.
[Full Text] [PDF]


Home page
CirculationHome page
S. A. Hunt, W. T. Abraham, M. H. Chin, A. M. Feldman, G. S. Francis, T. G. Ganiats, M. Jessup, M. A. Konstam, D. M. Mancini, K. Michl, et al.
ACC/AHA 2005 Guideline Update for the Diagnosis and Management of Chronic Heart Failure in the Adult--Summary Article: A Report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Writing Committee to Update the 2001 Guidelines for the Evaluation and Management of Heart Failure): Developed in Collaboration With the American College of Chest Physicians and the International Society for Heart and Lung Transplantation: Endorsed by the Heart Rhythm Society
Circulation, September 20, 2005; 112(12): 1825 - 1852.
[Full Text] [PDF]


Home page
J CARDIOVASC PHARMACOL THERHome page
E. R. Schwarz, R. Gupta, T. P. Diep, B. Nowak, S. Kostin, B. Grohmann, B. F. Uretsky, and J. Schaper
Carvedilol Improves Myocardial Contractility Compared With Metoprolol in Patients With Chronic Hibernating Myocardium After Revascularization
Journal of Cardiovascular Pharmacology and Therapeutics, July 1, 2005; 10(3): 181 - 190.
[Abstract] [PDF]


Home page
J Clin PharmacolHome page
B. F. McBride and C. M. White
Critical Differences Among Beta-Adrenoreceptor Antagonists in Myocardial Failure: Debating the MERIT of COMET
J. Clin. Pharmacol., January 1, 2005; 45(1): 6 - 24.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Heart Circ. Physiol.Home page
K. Kawai, F. Qin, J. Shite, W. Mao, S. Fukuoka, and C.-s. Liang
Importance of antioxidant and antiapoptotic effects of {beta}-receptor blockers in heart failure therapy
Am J Physiol Heart Circ Physiol, September 1, 2004; 287(3): H1003 - H1012.
[Abstract] [Full Text] [PDF]


Home page
J Am Coll CardiolHome page
T. E. Sirak, S. Jelic, and T. H. Le Jemtel
Therapeutic update: Non-selective beta- and alpha-adrenergic blockade in patients with coexistent chronic obstructive pulmonary disease and chronic heart failure
J. Am. Coll. Cardiol., August 4, 2004; 44(3): 497 - 502.
[Abstract] [Full Text] [PDF]


Home page
CirculationHome page
M. Penicka, J. Bartunek, B. De Bruyne, M. Vanderheyden, M. Goethals, M. De Zutter, P. Brugada, and P. Geelen
Improvement of Left Ventricular Function After Cardiac Resynchronization Therapy Is Predicted by Tissue Doppler Imaging Echocardiography
Circulation, March 2, 2004; 109(8): 978 - 983.
[Abstract] [Full Text] [PDF]


Home page
CirculationHome page
W. H. Barry and E. M. Gilbert
How Do {beta}-Blockers Improve Ventricular Function in Patients With Congestive Heart Failure?
Circulation, May 20, 2003; 107(19): 2395 - 2397.
[Full Text] [PDF]


Home page
J Am Coll CardiolHome page
T. Kubo, E. R. Azevedo, G. E. Newton, J. D. Parker, and J. S. Floras
Lack of evidence for peripheral alpha1- adrenoceptor blockade during long-term treatment of heart failure with carvedilol
J. Am. Coll. Cardiol., November 1, 2001; 38(5): 1463 - 1469.
[Abstract] [Full Text] [PDF]


Home page
ANN INTERN MEDHome page
J. M. Brophy, L. Joseph, and J. L. Rouleau
{beta}-Blockers in Congestive Heart Failure: A Bayesian Meta-Analysis
Ann Intern Med, April 3, 2001; 134(7): 550 - 560.
[Abstract] [Full Text] [PDF]


Home page
Eur Heart JHome page
C Opasich, G.D Pinna, A Mazza, O Febo, R Riccardi, P.G Riccardi, S Capomolla, G Forni, F Cobelli, and L Tavazzi
Six-minute walking performance in patients with moderate-to-severe heart failure; is it a useful indicator in clinical practice?
Eur. Heart J., March 2, 2001; 22(6): 488 - 496.
[Abstract] [PDF]


Home page
J Am Coll CardiolHome page
T. M. Ramahi, M. D. Longo, A. R. Cadariu, K. Rohlfs, S. A. Carolan, K. M. Engle, H. Samady, and F. J. T. Wackers
Left ventricular inotropic reserve and right ventricular function predict increase of left ventricular ejection fraction after beta-blocker therapy in nonischemic cardiomyopathy
J. Am. Coll. Cardiol., March 1, 2001; 37(3): 818 - 824.
[Abstract] [Full Text] [PDF]


Home page
J Am Coll CardiolHome page
M. L. Kukin, M. M. Mannino, R. S. Freudenberger, J. Kalman, C. Buchholz-Varley, and O. Ocampo
Hemodynamic comparison of twice daily metoprolol tartrate with once daily metoprolol succinate in congestive heart failure
J. Am. Coll. Cardiol., January 1, 2000; 35(1): 45 - 50.
[Abstract] [Full Text] [PDF]


Home page
J Am Coll CardiolHome page
A. Di Lenarda, G. Sabbadini, L. Salvatore, G. Sinagra, L. Mestroni, B. Pinamonti, D. Gregori, F. Ciani, A. Muzzi, S. Klugmann, et al.
Long-term effects of carvedilol in idiopathic dilated cardiomyopathy with persistent left ventricular dysfunction despite chronic metoprolol
J. Am. Coll. Cardiol., June 1, 1999; 33(7): 1926 - 1934.
[Abstract] [Full Text] [PDF]


Home page
J Am Coll CardiolHome page
P. S. Macdonald, A. M. Keogh, C. L. Aboyoun, M. Lund, R. Amor, and D. J. McCaffrey
Tolerability and efficacy of carvedilol in patients with New York Heart Association class IV heart failure
J. Am. Coll. Cardiol., March 15, 1999; 33(4): 924 - 931.
[Abstract] [Full Text] [PDF]


Home page
J CARDIOVASC PHARMACOL THERHome page
W. Carlson and K. Oberg
Clinical Pharmacology of Carvedilol
Journal of Cardiovascular Pharmacology and Therapeutics, January 1, 1999; 4(4): 205 - 218.
[Abstract] [PDF]


Home page
SEMIN CARDIOTHORAC VASC ANESTHHome page
W. T. Abraham
Pharmacologic Management of Chronic Heart Failure: A Review
Seminars in Cardiothoracic and Vascular Anesthesia, September 1, 1998; 2(3): 168 - 190.
[Abstract] [PDF]




HOME SUBSCRIPTIONS CURRENT ISSUE PAST ISSUES CARDIOSOURCE SEARCH HELP FEEDBACK
Copyright © 1995 by the American College of Cardiology Foundation.